Hubert Tseng

Hubert Tseng has an extensive work history in various scientific roles, starting as a Sr. Scientist at Nano3D Biosciences in 2013. Hubert transitioned to roles at The University of Texas Health Science Center, Targazyme, Valkos Bio, ChemoSen3D, and Salk Institute for Biological Studies before their current position as a Principal Scientist at Poseida Therapeutics, Inc. Hubert's roles have involved research and development, translational science, consulting, and fundraising in the field of biotechnology and oncology.

Hubert Tseng obtained a Bachelor of Science (BS) in Engineering Mechanics and Applied Mathematics & Statistics from The Johns Hopkins University in 2007. Hubert then earned a Doctor of Philosophy (PhD) in Bioengineering from Rice University in 2013. Additionally, they completed various certifications related to leadership, feedback, business acumen, and critical thinking from different institutions like LinkedIn and The Leadership Edge between 2021 and 2023.